Quality assurance in breast cancer: EORTC experiences in the phase III trial on irradiation of the internal mammary nodes.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  European Journal of Cancer

• Publication date

  2007-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/J.EJCA.2006.11.015PMID 17240136
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: An overview of the randomised trials

  2007cited by this paper
• Delaying radiotherapy for the delivery of adjuvant chemotherapy in the combined modality treatment of early breast cancer: is it disadvantageous and could combined treatment be the answer?

  2006cited by this paper
• Survival effects of postmastectomy adjuvant radiation therapy using biologically equivalent doses: a clinical perspective.

  2006cited by this paper
• Study of failure pattern among high-risk breast cancer patients with or without postmastectomy radiotherapy in addition to adjuvant systemic therapy: long-term results from the Danish Breast Cancer Cooperative Group DBCG 82 b and c randomized studies.

  2006cited by this paper
• Delay in initiating adjuvant radiotherapy following breast conservation surgery and its impact on survival.

  2006cited by this paper
• Timing of radiotherapy and survival benefit in breast cancer

  2006cited by this paper
• Complications of breast-cancer radiotherapy.

  2006cited by this paper
• Sequencing of chemotherapy and radiation therapy in early-stage breast cancer: updated results of a prospective randomized trial.

  2005cited by this paper
• Locoregional radiation therapy in patients with high-risk breast cancer receiving adjuvant chemotherapy: 20-year results of the British Columbia randomized trial.

  2005cited by this paper
• Influence of the time between surgery and radiotherapy on local recurrence in patients with lymph node‐positive, early‐stage, invasive breast carcinoma undergoing breast‐conserving surgery

  2005cited by this paper
• Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials.

  2005cited by this paper
• Internal Mammary Nodes in Invasive Breast Carcinoma

  2004cited by this paper
• Adjuvant radiotherapy for breast cancer: effects of longer follow-up.

  2004cited by this paper
• Internal mammary nodes in invasive breast carcinoma. To treat or not to treat?

  2004cited by this paper
• Trends in postoperative radiotherapy delay and the effect on survival in breast cancer patients treated with conservation surgery

  2004cited by this paper
• Incidence of internal mammary node metastases after a sentinel lymph node technique in breast cancer and its implication in the radiotherapy plan.

  2004cited by this paper
• Quality assurance of EORTC trial 22922/10925 investigating the role of internal mammary--medial supraclavicular irradiation in stage I-III breast cancer: the individual case review.

  2003cited by this paper
• The role of irradiation of the internal mammary lymph nodes in high-risk stage II to IIIA breast cancer patients after high-dose chemotherapy: a prospective sequential nonrandomized study.

  2003cited by this paper
• Does delay in starting treatment affect the outcomes of radiotherapy? A systematic review.

  2003cited by this paper
• Stage migration after biopsy of internal mammary chain lymph nodes in breast cancer patients

  2002cited by this paper
• The potential impact of treatment variations on the results of radiotherapy of the internal mammary lymph node chain: a quality-assurance report on the dummy run of EORTC Phase III randomized trial 22922/10925 in Stage I--III breast cancer(1).

  2001cited by this paper
• Favourable and unfavourable effects on long-term survival of radiotherapy for early breast cancer: an overview of the randomised trials

  2000cited by this paper
• Internal mammary node irradiation neither decreases distant metastases nor improves survival in stage I and II breast cancer.

  2000cited by this paper
• Relationship between tumor location and relapse in 6,781 women with early invasive breast cancer.

  2000cited by this paper
• Does locoregional radiation therapy improve survival in breast cancer? A meta-analysis.

  2000cited by this paper
• Favourable and unfavourable effects on long-term survival of radiotherapy for early breast cancer: an overview of the randomised trials

  2000cited by this paper
• Favourable and unfavourable effects on long-term survival of radiotherapy for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group.

  2000cited by this paper
• Internal mammary nodal irradiation in conservatively-managed breast cancer patients: is there a benefit?

  1999cited by this paper
• The sequencing of chemotherapy and radiation therapy after conservative surgery for early-stage breast cancer.

  1996cited by this paper
• The impact of radiation on early breast carcinoma survival: A Bayesian analysis

  1996cited by this paper
• Tangential breast irradiation with or without internal mammary chain irradiation: results of a randomized trial.

  1995cited by this paper
• Influences on inferences. Effect of errors in data on statistical evaluation

  1993cited by this paper
• Prescribing, recording, and reporting photon beam therapy

  1993cited by this paper
• The radiation dose-response relationship for control of primary breast cancer.

  1986cited by this paper

• The impact of isolated local recurrence on long-term outcome in early-breast cancer patients after breast-conserving therapy.

  2021cites this paper
• Quality of Regional Nodal Irradiation Plans in Breast Cancer Patients Across a Large Network - Can We Translate Results from Randomized Trials into the Clinic?

  2020cites this paper
• Optimal Target Delineation and Treatment Techniques in the Era of Conformal Photon and Proton Breast and Regional Nodal Irradiation: Breast Nodal Optimal Target Delineation.

  2019cites this paper
• Practice-changing radiation therapy trials for the treatment of cancer: where are we 150 years after the birth of Marie Curie?

  2018cites this paper
• Most Breast Cancer Patients with T1-2 Tumors and One to Three Positive Lymph Nodes Do Not Need Postmastectomy Radiotherapy

  2018cites this paper
• Chapter 63 – Breast Cancer: Stages I-II

  2016cites this paper
• DBCG-IMN: A Population-Based Cohort Study on the Effect of Internal Mammary Node Irradiation in Early Node-Positive Breast Cancer.

  2016influential citation
• Phase II Clinical Trial of Concurrent Neoadjuvant Chemotherapy With Radiotherapy in Locally Advanced Breast Cancer

  2015cites this paper
• Internal Mammary and Medial Supraclavicular Irradiation in Breast Cancer.

  2015cites this paper
• Quality assurance in MR image guided adaptive brachytherapy for cervical cancer: Final results of the EMBRACE study dummy run.

  2015cites this paper
• Breast-Conserving Therapy: A Viable Option for Young Women with Early Breast Cancer—Evidence from a Prospective Study

  2014cites this paper
• Locoregional therapy of locally advanced breast cancer: a clinical practice guideline.

  2014cites this paper
• Quality assurance of conventional non-CT-based internal mammary lymph node irradiation in a prospective Danish Breast Cancer Cooperative Group trial: The DBCG-IMN study

  2013cites this paper
• Does quality of radiation therapy predict outcomes of multicenter cooperative group trials? A literature review.

  2013cites this paper
• Adjuvant radiotherapy of regional lymph nodes in breast cancer - a meta-analysis of randomized trials

  2013cites this paper
• Ten-year survival results of a randomized trial of irradiation of internal mammary nodes after mastectomy.

  2013cites this paper
• Breast Cancer Guidelines Expert Panel

  2013cites this paper
• Breast cancer in women

  2013cites this paper
• 140 DOES QUALITY OF RADIOTHERAPY PREDICT OUTCOMES OF MULTICENTRE COOPERATIVE GROUP TRIALS? A LITERATURE REVIEW.

  2012cites this paper
• EORTC Radiation Oncology Group: 50 years of continuous accomplishments

  2012cites this paper
• Axillary and Supraclavicular Recurrences are Rare after Axillary Lymph Node Dissection in Breast Cancer

  2012cites this paper
• Compliance with therapeutic guidelines in Radiation Therapy Oncology Group prospective gastrointestinal clinical trials.

  2012cites this paper
• Development of clinical trial protocols involving advanced radiation therapy techniques: the European Organisation for Research and Treatment of Cancer Radiation Oncology Group approach.

  2012cites this paper
• Wetenschappelijke ondersteuning van het college voor Oncologie: een update van de nationale richtlijn voor testikanker.

  2010cites this paper
• Increased use of regional radiotherapy is associated with improved outcome in a population-based cohort of women with breast cancer with 1-3 positive nodes.

  2010cites this paper
• Toxicity at three years with and without irradiation of the internal mammary and medial supraclavicular lymph node chain in stage I to III breast cancer (EORTC trial 22922/10925)

  2010cites this paper
• [Monocentric evaluation of the skin and cardiac toxicities of the concomitant administration of trastuzumab and radiotherapy].

  2009cites this paper
• Guidelines for International Breast Health and Cancer Control – Implementation Supplement to Cancer Breast Radiation Therapy Guideline Implementation in Low-and Middle-Income Countries

  2008cites this paper
• EORTC 22972-26991/MRC BR10 trial: fractionated stereotactic boost following conventional radiotherapy of high grade gliomas. Clinical and quality-assurance results of the stereotactic boost arm.

  2008cites this paper
• Breast radiation therapy guideline implementation in low‐ and middle‐income countries

  2008cites this paper
• Profile of European radiotherapy departments contributing to the EORTC Radiation Oncology Group (ROG) in the 21st century.

  2008cites this paper